Table 2.
Probiotic species | Antibiotic resistance | Reference |
---|---|---|
B. longum JDM301 | Ciprofloxacin, amikacin, gentamicin, streptomycin | Wei et al. (2012) |
B. longum2 | Kanamycin | Temmerman et al. (2003) |
B. lactis2 | Kanamycin | Temmerman et al. (2003) |
L. rhamnosus1 | Vancomycin, teicoplanin, bacitracin, aminoglycosides | Charteris et al. (1998), Danielsen and Wind (2003) |
L. casei1 | ||
L. paracasei1 | ||
L. plantarum1 | ||
L. acidophilus1 | ||
L. reuteri2 | Kanamycin, tetracycin, penicillin, vancomycin | Temmerman et al. (2003) |
L. casei2 | Kanamycin, vancomycin | Temmerman et al. (2003) |
L. acidophilus2 | Kanamycin | Temmerman et al. (2003) |
E. faecalis1 | Beta-lactams | Yamaguchi et al. (2013) |
Vancomycin | Werner et al. (2008) | |
B. adolescentis2 | Kanamycin, neomycin, streptomycin, nalidixic acid | Kheadr et al. (2004) |
B. animalis2 | ||
B. longum2 | ||
B. bifidum2 | ||
P. pentosaceus | Vancomycin, teicoplanin | Biavasco et al. (1997) |
P. acidilactici | Vancomycin | Temmerman et al. (2003) |
1Antibiotic resistance is indicated for more than 50% of isolates/strains used in the study, which were related to the species.
2Antibiotic resistance is indicated for 100% isolates/strains used in the study, which were related to the species.